Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

phVEGF-2 therapy shows promising results in human pilot study

May 17, 2001

New indole-based sPLA2 inhibitors in development at Lilly

May 16, 2001

Avant initiates second phase IIb trial of TP-10 in infants

May 15, 2001

Inhibitors of VSMC proliferation derived from PGE reported by Taisho

May 14, 2001

Plans to codevelop ACAT inhibitor for atherosclerosis announced by Lilly, bioMerieux-Pierre Fabre

May 10, 2001

Bayer describes dicarboxylic acid derivatives useful for cardiovascular disorders

May 8, 2001

Electrophysiological profile of amiodarone homologues examined in guinea pig hearts

May 8, 2001

Taiwan researchers study plant-derived sesquiterpene as potential antihypertensive agent

May 8, 2001

NS-3623: a long-acting, reversible Cl conductance blocker for sickle cell disease

May 7, 2001

Novartis files for approval of Diovan for heart failure in several countries

May 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...